Ah yeah maybe I'm wrong. From commsec. Think this is with current shares that HHI is calculated at. The other Agres don't land for another 11 months.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%